219 related articles for article (PubMed ID: 33859739)
21. Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins.
Li K; Huo Q; Dimmitt NH; Qu G; Bao J; Pandya PH; Saadatzadeh MR; Bijangi-Vishehsaraei K; Kacena MA; Pollok KE; Lin CC; Li BY; Yokota H
Elife; 2023 Mar; 12():. PubMed ID: 36943734
[TBL] [Abstract][Full Text] [Related]
22. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
[TBL] [Abstract][Full Text] [Related]
23. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF.
Zhang P; Dong L; Yan K; Long H; Yang TT; Dong MQ; Zhou Y; Fan QY; Ma BA
Oncol Rep; 2013 Oct; 30(4):1753-61. PubMed ID: 23863999
[TBL] [Abstract][Full Text] [Related]
24. Mesenchymal stem cells promote mammary cancer cell migration in vitro via the CXCR2 receptor.
Halpern JL; Kilbarger A; Lynch CC
Cancer Lett; 2011 Sep; 308(1):91-9. PubMed ID: 21601983
[TBL] [Abstract][Full Text] [Related]
25. Embryonic stem cell preconditioned microenvironment suppresses tumorigenic properties in breast cancer.
He N; Feng G; Li Y; Xu Y; Xie X; Wang H; Wang Y; Ou L; Pei X; Liu N; Li Z
Stem Cell Res Ther; 2016 Jul; 7(1):95. PubMed ID: 27460364
[TBL] [Abstract][Full Text] [Related]
26. Anti-IL-20 monoclonal antibody suppresses breast cancer progression and bone osteolysis in murine models.
Hsu YH; Hsing CH; Li CF; Chan CH; Chang MC; Yan JJ; Chang MS
J Immunol; 2012 Feb; 188(4):1981-91. PubMed ID: 22238453
[TBL] [Abstract][Full Text] [Related]
27. CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.
Sharma B; Nannuru KC; Saxena S; Varney ML; Singh RK
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30871004
[TBL] [Abstract][Full Text] [Related]
28. Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells.
Park J; Lee JH; Yoon BS; Jun EK; Lee G; Kim IY; You S
Stem Cell Res Ther; 2018 Nov; 9(1):293. PubMed ID: 30409167
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.
Atsuta I; Liu S; Miura Y; Akiyama K; Chen C; An Y; Shi S; Chen FM
Stem Cell Res Ther; 2013; 4(5):111. PubMed ID: 24025590
[TBL] [Abstract][Full Text] [Related]
31. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stem cells promote colorectal cancer progression through AMPK/mTOR-mediated NF-κB activation.
Wu XB; Liu Y; Wang GH; Xu X; Cai Y; Wang HY; Li YQ; Meng HF; Dai F; Jin JD
Sci Rep; 2016 Feb; 6():21420. PubMed ID: 26892992
[TBL] [Abstract][Full Text] [Related]
33. Gastric cancer tissue-derived mesenchymal stem cells impact peripheral blood mononuclear cells via disruption of Treg/Th17 balance to promote gastric cancer progression.
Wang M; Chen B; Sun XX; Zhao XD; Zhao YY; Sun L; Xu CG; Shen B; Su ZL; Xu WR; Zhu W
Exp Cell Res; 2017 Dec; 361(1):19-29. PubMed ID: 28964780
[TBL] [Abstract][Full Text] [Related]
34. Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice.
An JH; Park H; Song JA; Ki KH; Yang JY; Choi HJ; Cho SW; Kim SW; Kim SY; Yoo JJ; Baek WY; Kim JE; Choi SJ; Oh W; Shin CS
Tissue Eng Part A; 2013 Mar; 19(5-6):685-96. PubMed ID: 23215868
[TBL] [Abstract][Full Text] [Related]
35. Vascular endothelial growth factor over-expressed mesenchymal stem cells-conditioned media ameliorate palmitate-induced diabetic endothelial dysfunction through PI-3K/AKT/m-TOR/eNOS and p38/MAPK signaling pathway.
Xu T; Lv Z; Chen Q; Guo M; Wang X; Huang F
Biomed Pharmacother; 2018 Oct; 106():491-498. PubMed ID: 29990837
[TBL] [Abstract][Full Text] [Related]
36. Pitavastatin slows tumor progression and alters urine-derived volatile organic compounds through the mevalonate pathway.
Wang L; Wang Y; Chen A; Teli M; Kondo R; Jalali A; Fan Y; Liu S; Zhao X; Siegel A; Minami K; Agarwal M; Li BY; Yokota H
FASEB J; 2019 Dec; 33(12):13710-13721. PubMed ID: 31585508
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
[TBL] [Abstract][Full Text] [Related]
39. Tumor-supportive and osteoclastogenic changes induced by breast cancer-derived factors are reversed by inhibition of {gamma}-secretase.
Fong JE; Le Nihouannen D; Komarova SV
J Biol Chem; 2010 Oct; 285(41):31427-34. PubMed ID: 20679341
[TBL] [Abstract][Full Text] [Related]
40. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
